Glipizide
- Product NDC
- 68071-4010
- 11-digit product format
- 680714010
- Labeler code
- 68071
- Product ID
- 68071-4010_54c23582-efe7-3d9d-e054-00144ff8d46c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Glipizide
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- ANDA076467
- Marketing category
- ANDA
- Marketing start
- 2003-11-07
- Marketing end
- 0000-00-00
- Substance
- GLIPIZIDE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Sulfonylurea [EPC],Sulfonylurea Compounds [CS]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68071-4010-2 | 2020-05-22 | C162847 | 48780-1 | 9d75b9d0-b833-f424-e053-dadaa90a57ce | 54c23582-efe6-3d9d-e054-00144ff8d46c |
| 68071-4010-3 | 2020-05-22 | C162847 | 48780-1 | 9d75b9d0-b833-f424-e053-dadaa90a57ce | 54c23582-efe6-3d9d-e054-00144ff8d46c |
| 68071-4010-6 | 2020-05-22 | C162847 | 48780-1 | 9d75b9d0-b833-f424-e053-dadaa90a57ce | 54c23582-efe6-3d9d-e054-00144ff8d46c |
| 68071-4010-8 | 2020-05-22 | C162847 | 48780-1 | 9d75b9d0-b833-f424-e053-dadaa90a57ce | 54c23582-efe6-3d9d-e054-00144ff8d46c |
| 68071-4010-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-b833-f424-e053-dadaa90a57ce | 54c23582-efe6-3d9d-e054-00144ff8d46c |
| 68071-4010-3 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-b833-f424-e053-dadaa90a57ce | 54c23582-efe6-3d9d-e054-00144ff8d46c |
| 68071-4010-6 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-b833-f424-e053-dadaa90a57ce | 54c23582-efe6-3d9d-e054-00144ff8d46c |
| 68071-4010-8 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-b833-f424-e053-dadaa90a57ce | 54c23582-efe6-3d9d-e054-00144ff8d46c |